Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of EVMN will rise by +1.12% over the next 2 Weeks and hit $17.50 by Friday, February 20, 2026. In that time frame, EVMN's share price is expected to range between $15.79 and $19.10.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Feb 20, 2026 | 15.79 | 17.50 | 19.10 |
| Feb 19, 2026 | 16.49 | 18.12 | 19.80 |
| Feb 18, 2026 | 15.74 | 17.40 | 19.14 |
| Feb 17, 2026 | 15.48 | 17.21 | 18.84 |
| Feb 16, 2026 | 15.73 | 17.37 | 19.07 |
| Feb 13, 2026 | 15.36 | 17.09 | 18.80 |
| Feb 12, 2026 | 16.14 | 17.70 | 19.27 |
| Feb 11, 2026 | 15.32 | 16.98 | 18.56 |
| Feb 10, 2026 | 15.11 | 16.79 | 18.45 |
| Feb 9, 2026 | 15.25 | 16.95 | 18.52 |
EVMN shares rose +3.90% in Friday, February 6, 2026's trading session, rising from a previous close of $16.66 to move at $17.31. The stock demonstrated notable intraday movement (see EVMN's key stats for a full breakdown), fluctuating between $17.00 and $17.59, a +3.44% trading range. While recent weeks have seen some volatility, EVMN has managed to secure a -11.59% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 204.38K shares changing hands, 3.91K fewer than the previous session. This amounted to $3.54M in total market activity.
Will EVMN Continue Its Upward Trend?
According to analyst ratings and projections for EVMN, Evommune, Inc. shares are anticipated to increase by +9.39%, potentially reaching $19.10 per share by February 20, 2026. Short-term technical indicators currently suggest a neutral sentiment for EVMN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 18 positive trading days within the past 30 sessions. Based on the EVMN stock forecast, now is a good time to buy EVMN stock because its current trading price is -1.11% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on EVMN covering social and institutional perspectives.
EVMN Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into EVMN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 42.40% to 46.23%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 47.10%, suggests a neutral medium-term outlook. Insights into EVMN's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Evommune Short-Term Forecasts
EVMN Forecast For Next 5 Days
Our algorithm anticipates Evommune (EVMN) stock could hit $19.65 by Feb 13, 2026. This represents a +13.53% fall from today's price, following a -12.96% change over the past five days.
EVMN Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Evommune, Inc. (EVMN) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $19.35, which would mean a +11.79% increase from the current price of $17.31. Projections for this period range from a high of $22.17 to a low of $16.16.
EVMN Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Evommune's price over the next three months point to a rise. EVMN stock is expected to peak at $219.55 on Feb 23, 2026 before potentially dipping to $0.00 on Mar 13, 2026. On average, EVMN is likely to trade around $54.47 in the coming 90 days.
Evommune Stock Forecast 2025
Based on our predictive models, Evommune (EVMN) is expected to trade between $0.00 and $260.39 throughout 2026. This would result in an average price of $62.88, potentially offering investors a +263.26% return from current levels.
Evommune, Inc. Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Evommune, Inc. (EVMN) is positioned to show a strong performance in February 2026. The price is predicted to move between $19.94 and $219.55, settling at an average of $119.62. This could translate to a +591.05% gain.
March 2026
Based on current market signals, Evommune, Inc. is projected to trend march 2026. We forecast a trading range from $0.00 to $90.98, with a likely average price of $30.70. Investors could expect a potential return of +77.35%.
April 2026
Our predictive algorithms indicate Evommune, Inc. stock may see a shift in April 2026. The expected range spans $24.41–$40.19, with an average target of $36.60. This represents a positive outlook and a possible gain of +111.44%.
May 2026
Analyzing established trends, Evommune, Inc. looks set to move in May 2026. Projections place the stock between $34.78 and $40.33, averaging around $36.81. This suggests a +112.65% gain from current levels.
June 2026
Market indicators suggest Evommune, Inc. could experience notable changes during June 2026. Prices could fluctuate within $33.81 to $39.47, with a midpoint forecast of $37.12. The stock might deliver a +114.44% gain.
July 2026
Forecasting for July 2026, models estimate that Evommune, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $3.88 and $240.59, averaging $103.45. This signals a positive trajectory with potential returns around +497.63%.
August 2026
According to our latest forecast models, Evommune, Inc. (EVMN) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.00 and $112.04, settling at an average of $45.54. This could translate to a +163.08% gain.
September 2026
Based on current market signals, Evommune, Inc. is projected to trend september 2026. We forecast a trading range from $54.66 to $61.42, with a likely average price of $58.81. Investors could expect a potential return of +239.75%.
October 2026
Our predictive algorithms indicate Evommune, Inc. stock may see a shift in October 2026. The expected range spans $54.84–$60.75, with an average target of $57.23. This represents a positive outlook and a possible gain of +230.62%.
November 2026
Analyzing established trends, Evommune, Inc. looks set to move in November 2026. Projections place the stock between $55.76 and $60.44, averaging around $58.58. This suggests a +238.42% gain from current levels.
December 2026
Market indicators suggest Evommune, Inc. could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $260.39, with a midpoint forecast of $118.70. The stock might deliver a +585.73% gain.
January 2027
Forecasting for January 2027, models estimate that Evommune, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $133.03, averaging $66.61. This signals a positive trajectory with potential returns around +284.81%.
February 2027
According to our latest forecast models, Evommune, Inc. (EVMN) is positioned to show a strong performance in February 2027. The price is predicted to move between $79.15 and $80.36, settling at an average of $79.79. This could translate to a +360.95% gain.
EVMN's history of dividends and stock splits also plays a role in long-term investor confidence.

